{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:42:19Z","timestamp":1777509739768,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI111925"],"award-info":[{"award-number":["AI111925"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD001262-18"],"award-info":[{"award-number":["K12HD001262-18"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012297","name":"Society of Family Planning","doi-asserted-by":"publisher","award":["K12HD001262-18"],"award-info":[{"award-number":["K12HD001262-18"]}],"id":[{"id":"10.13039\/100012297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.contraception.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T06:21:58Z","timestamp":1601446918000},"page":"44-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay"],"prefix":"10.1016","volume":"103","author":[{"given":"Dominika","family":"Seidman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Cavrois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan F.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia R.","family":"Roan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Averbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-4351","authenticated-orcid":false,"given":"Nandhini","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara L.","family":"Shacklett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-3748","authenticated-orcid":false,"given":"Karen","family":"Smith-McCune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2020.09.003_b0005","unstructured":"Contraceptive Use by Method 2019: Data Booklet (ST\/ESA\/SER.A\/435): United Nations, Department of Economic and Social Affairs, Population Division 2019. Available from: https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Jan\/un_2019_contraceptiveusebymethod_databooklet.pdf."},{"issue":"2","key":"10.1016\/j.contraception.2020.09.003_b0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(14)71052-7","article-title":"Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies","volume":"15","author":"Ralph","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.contraception.2020.09.003_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0b013e32835a5a52","article-title":"Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk","volume":"27","author":"Butler","year":"2013","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.contraception.2020.09.003_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001778","article-title":"Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis","volume":"12","author":"Morrison","year":"2015","journal-title":"PLoS Med"},{"issue":"10195","key":"10.1016\/j.contraception.2020.09.003_b0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","article-title":"Outcomes Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"394","author":"Evidence for Contraceptive Options H. I. V.","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2020.09.003_b0030","unstructured":"Contraceptive eligibility for women at high risk of HIV. Guidance statement. : World Health Organization; 2019. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/326653\/9789241550574-eng.pdf;jsessionid=30D60736C4FEC24189B9A7E8CC775997?ua=1."},{"issue":"1","key":"10.1016\/j.contraception.2020.09.003_b0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiy113","article-title":"Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: A prospective per-coital-act analysis among women with HIV-infected partners","volume":"218","author":"Thomson","year":"2018","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.contraception.2020.09.003_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001608","article-title":"Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis","volume":"11","author":"Drake","year":"2014","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.contraception.2020.09.003_b0045","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt745","article-title":"A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes","volume":"20","author":"Cavrois","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.contraception.2020.09.003_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221181","article-title":"Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo","volume":"14","author":"Cavrois","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.contraception.2020.09.003_b0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20090378","article-title":"Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection","volume":"206","author":"Salazar-Gonzalez","year":"2009","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.contraception.2020.09.003_b0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/COH.0b013e32833a8844","article-title":"Contribution of sexually transmitted infections to the sexual transmission of HIV","volume":"5","author":"Ward","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"10.1016\/j.contraception.2020.09.003_b0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/JVI.01730-14","article-title":"Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1","volume":"89","author":"Quillay","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.contraception.2020.09.003_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mi.2015.28","article-title":"Identification of preferential CD4+ T-cell targets for HIV infection in the cervix","volume":"9","author":"Joag","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"6","key":"10.1016\/j.contraception.2020.09.003_b0075","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2007.10.014","article-title":"Semen-derived amyloid fibrils drastically enhance HIV infection","volume":"131","author":"Munch","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.contraception.2020.09.003_b0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.01366-08","article-title":"The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection","volume":"83","author":"Roan","year":"2009","journal-title":"J Virol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420303437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420303437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:35:31Z","timestamp":1777390531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782420303437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0010782420303437"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2020.09.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}